Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,101,583 papers from all fields of science
Search
Sign In
Create Free Account
TJ 14
Known as:
TJ-14
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
hange-shashinto
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
The clinical effect of Kampo medicine in multimodal treatment for Gastrointestinal Cancer in Japan
T. Aoyama
,
H. Tamagawa
Journal of Cancer
2020
Corpus ID: 220486530
Kampo medicine or Japanese/Chinese traditional herbal medicine has long been used for the treatment of various diseases, mainly…
Expand
Review
2018
Review
2018
Inhibitory Effects of Baicalein Derived from Japanese Traditional Herbal Medicine on SN-38 Glucuronidation.
T. Satoh
,
Ayaka Igarashi
,
Misaki Tanno
,
Koki Yamada
,
Natsuko Takahashi-Suzuki
,
Kazuhiro Watanabe
Journal of Pharmacy & Pharmaceutical Sciences
2018
Corpus ID: 48357878
PURPOSE The chemotherapeutic agent irinotecan is hydrolyzed to its active form SN-38 by human carboxyesterases, but SN-38 is…
Expand
2017
2017
Effects of shinbuto and ninjinto on prostaglandin E2 production in lipopolysaccharide-treated human gingival fibroblasts
T. Ara
,
N. Sogawa
PeerJ
2017
Corpus ID: 24458662
Previously, we revealed that several kampo medicines used for patients with excess and/or medium patterns (kakkonto (TJ-1…
Expand
2017
2017
Meta-analysis of Patient-level Data on Therapeutic Effects of TJ-14 (Hangeshashinto) for Gastroenterological Cancer Chemotherapy-induced Severe Oral Mucositis with the HANGESHA-G and HANGESHA-Cs…
T. Aoyama
,
K. Nishikawa
,
+15 authors
J. Sakamoto
2017
Corpus ID: 79499885
This meta-analysis will be performed to evaluate the efficacy of Hangeshashinto (TJ-14) in patients with chemotherapy- induced…
Expand
2011
2011
Topical application of hangeshashinto (TJ-14) in the management of chemotherapy-induced oral mucositis: A preliminary study.
T. Kono
,
M. Satomi
,
+5 authors
H. Furukawa
Journal of Clinical Oncology
2011
Corpus ID: 41791996
603 Background: Oral mucositis is a common toxicity associated with cytotoxic chemotherapy used for cancer treatment and results…
Expand
2011
2011
Care by Kampo medicine for toxicities of colorectal cancer chemotherapy: Effect of goshajinkigan (TJ-107) and powdered processed aconite root (TJ-3023) on oxaliplatin-related neurotoxicity, and…
Y. Shindo
,
H. Andoh
Journal of Clinical Oncology
2011
Corpus ID: 45522342
601 Background: FOLFOX is standard therapy of advanced-stage colorectal cancer. Sensory neurotoxicity (SN) with oxaliplatin is…
Expand
1998
1998
Effects of Hange-shashin-to on cholera toxin-induced fluid secretion in the small intestine of rats.
Y. Kase
,
K. Saitoh
,
M. Yuzurihara
,
A. Ishige
,
Y. Komatsu
Biological and Pharmaceutical Bulletin
1998
Corpus ID: 45614774
The effects of Hange-shashin-to (TJ-14) on cholera toxin-induced intestinal fluid secretion were studied to elucidate the…
Expand
1998
1998
[Kampo medicines for the prevention of irinotecan-induced diarrhea in advanced non-small cell lung cancer].
K. Mori
,
T. Hirose
,
S. Machida
,
K. Tominaga
Gan to kagaku ryoho. Cancer & chemotherapy
1998
Corpus ID: 28072193
A combination of irinotecan hydrochloride (CPT-11; 160 mg/m2, intravenous infusion, day 1) and cisplatin (5-day continuous…
Expand
1997
1997
The effects of hange-shashin-to on gastric function in comparison with sho-saiko-to.
Y. Kase
,
M. Yuzurihara
,
S. Iizuka
,
A. Ishige
,
Y. Komatsu
Biological and Pharmaceutical Bulletin
1997
Corpus ID: 20813943
The effects of "Hange-shashin-to (TJ-14)" on gastric function were examined in comparison with "Sho-saiko-to (TJ-9)". Oral…
Expand
1996
1996
Pharmacological studies on antidiarrheal effects of Hange-shashin-to.
Y. Kase
,
T. Hayakawa
,
S. Takeda
,
A. Ishige
,
M. Aburada
,
M. Okada
Biological and Pharmaceutical Bulletin
1996
Corpus ID: 20492231
We attempted to characterize the antidiarrheal action of Hange-shashin-to (TJ-14), a kampo medicine, by comparing its action with…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE